Industry Growth Insights published a new data on “HIV Diagnostics Market”. The research report is titled “HIV Diagnostics Market research by Types (Consumables, Assay, Kits and Reagents, Other Consumables, Instruments, Software and Services), By Applications (Antibody Tests, Viral Load Tests, CD4 Tests, Tests for Early Infant Diagnosis, Tests for Viral Identification), By Players/Companies Abbott, Abbott Healthcare, Abbvie Inc., Brsitol-Myers Squibb, Janssen Therapeutics, Gilead Sciences, Merck & Co. Inc, VIIV Healthcare, BD Biosciences, Beckman Coulter, Partec, Sysmex, Apogee Flow Systems, PointCare Technologies Inc., Zyomyx Inc., Mylan inc., Roche Diagnostics, Siemens Healthcare, Qiagen, BioMerieux”.
Scope Of The Report
Report Attributes
Report Details
Report Title
HIV Diagnostics Market Research Report
By Type
Consumables, Assay, Kits and Reagents, Other Consumables, Instruments, Software and Services
By Application
Antibody Tests, Viral Load Tests, CD4 Tests, Tests for Early Infant Diagnosis, Tests for Viral Identification
By Companies
Abbott, Abbott Healthcare, Abbvie Inc., Brsitol-Myers Squibb, Janssen Therapeutics, Gilead Sciences, Merck & Co. Inc, VIIV Healthcare, BD Biosciences, Beckman Coulter, Partec, Sysmex, Apogee Flow Systems, PointCare Technologies Inc., Zyomyx Inc., Mylan inc., Roche Diagnostics, Siemens Healthcare, Qiagen, BioMerieux
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
183
Number of Tables & Figures
129
Customization Available
Yes, the report can be customized as per your need.
Global HIV Diagnostics Market Report Segments:
The global HIV Diagnostics market is segmented on the basis of:
Types
Consumables, Assay, Kits and Reagents, Other Consumables, Instruments, Software and Services
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Antibody Tests, Viral Load Tests, CD4 Tests, Tests for Early Infant Diagnosis, Tests for Viral Identification
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- Abbott Healthcare
- Abbvie Inc.
- Brsitol-Myers Squibb
- Janssen Therapeutics
- Gilead Sciences
- Merck & Co. Inc
- VIIV Healthcare
- BD Biosciences
- Beckman Coulter
- Partec
- Sysmex
- Apogee Flow Systems
- PointCare Technologies Inc.
- Zyomyx Inc.
- Mylan inc.
- Roche Diagnostics
- Siemens Healthcare
- Qiagen
- BioMerieux
Highlights of The HIV Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Consumables
- Assay, Kits and Reagents
- Other Consumables
- Instruments
- Software and Services
- By Application:
- Antibody Tests
- Viral Load Tests
- CD4 Tests
- Tests for Early Infant Diagnosis
- Tests for Viral Identification
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the HIV Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
HIV Diagnostics is a term used to describe any tests or procedures that are used to diagnose HIV infection. HIV diagnostic tests can be done on blood, saliva, semen, vaginal fluid, or other body fluids.
Some of the major companies in the hiv diagnostics market are Abbott, Abbott Healthcare, Abbvie Inc., Brsitol-Myers Squibb, Janssen Therapeutics, Gilead Sciences, Merck & Co. Inc, VIIV Healthcare, BD Biosciences, Beckman Coulter, Partec, Sysmex, Apogee Flow Systems, PointCare Technologies Inc., Zyomyx Inc., Mylan inc., Roche Diagnostics, Siemens Healthcare, Qiagen, BioMerieux.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 HIV Diagnostics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 HIV Diagnostics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 HIV Diagnostics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the HIV Diagnostics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global HIV Diagnostics Market Size & Forecast, 2018-2028
4.5.1 HIV Diagnostics Market Size and Y-o-Y Growth
4.5.2 HIV Diagnostics Market Absolute $ Opportunity
Chapter 5 Global HIV Diagnostics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 HIV Diagnostics Market Size Forecast by Type
5.2.1 Consumables
5.2.2 Assay
5.2.3 Kits and Reagents
5.2.4 Other Consumables
5.2.5 Instruments
5.2.6 Software and Services
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global HIV Diagnostics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 HIV Diagnostics Market Size Forecast by Applications
6.2.1 Antibody Tests
6.2.2 Viral Load Tests
6.2.3 CD4 Tests
6.2.4 Tests for Early Infant Diagnosis
6.2.5 Tests for Viral Identification
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global HIV Diagnostics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 HIV Diagnostics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America HIV Diagnostics Analysis and Forecast
9.1 Introduction
9.2 North America HIV Diagnostics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America HIV Diagnostics Market Size Forecast by Type
9.6.1 Consumables
9.6.2 Assay
9.6.3 Kits and Reagents
9.6.4 Other Consumables
9.6.5 Instruments
9.6.6 Software and Services
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America HIV Diagnostics Market Size Forecast by Applications
9.10.1 Antibody Tests
9.10.2 Viral Load Tests
9.10.3 CD4 Tests
9.10.4 Tests for Early Infant Diagnosis
9.10.5 Tests for Viral Identification
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe HIV Diagnostics Analysis and Forecast
10.1 Introduction
10.2 Europe HIV Diagnostics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe HIV Diagnostics Market Size Forecast by Type
10.6.1 Consumables
10.6.2 Assay
10.6.3 Kits and Reagents
10.6.4 Other Consumables
10.6.5 Instruments
10.6.6 Software and Services
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe HIV Diagnostics Market Size Forecast by Applications
10.10.1 Antibody Tests
10.10.2 Viral Load Tests
10.10.3 CD4 Tests
10.10.4 Tests for Early Infant Diagnosis
10.10.5 Tests for Viral Identification
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific HIV Diagnostics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific HIV Diagnostics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific HIV Diagnostics Market Size Forecast by Type
11.6.1 Consumables
11.6.2 Assay
11.6.3 Kits and Reagents
11.6.4 Other Consumables
11.6.5 Instruments
11.6.6 Software and Services
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific HIV Diagnostics Market Size Forecast by Applications
11.10.1 Antibody Tests
11.10.2 Viral Load Tests
11.10.3 CD4 Tests
11.10.4 Tests for Early Infant Diagnosis
11.10.5 Tests for Viral Identification
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America HIV Diagnostics Analysis and Forecast
12.1 Introduction
12.2 Latin America HIV Diagnostics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America HIV Diagnostics Market Size Forecast by Type
12.6.1 Consumables
12.6.2 Assay
12.6.3 Kits and Reagents
12.6.4 Other Consumables
12.6.5 Instruments
12.6.6 Software and Services
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America HIV Diagnostics Market Size Forecast by Applications
12.10.1 Antibody Tests
12.10.2 Viral Load Tests
12.10.3 CD4 Tests
12.10.4 Tests for Early Infant Diagnosis
12.10.5 Tests for Viral Identification
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) HIV Diagnostics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) HIV Diagnostics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) HIV Diagnostics Market Size Forecast by Type
13.6.1 Consumables
13.6.2 Assay
13.6.3 Kits and Reagents
13.6.4 Other Consumables
13.6.5 Instruments
13.6.6 Software and Services
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) HIV Diagnostics Market Size Forecast by Applications
13.10.1 Antibody Tests
13.10.2 Viral Load Tests
13.10.3 CD4 Tests
13.10.4 Tests for Early Infant Diagnosis
13.10.5 Tests for Viral Identification
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 HIV Diagnostics Market: Competitive Dashboard
14.2 Global HIV Diagnostics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 Abbott Healthcare
14.3.3 Abbvie Inc.
14.3.4 Brsitol-Myers Squibb
14.3.5 Janssen Therapeutics
14.3.6 Gilead Sciences
14.3.7 Merck & Co. Inc
14.3.8 VIIV Healthcare
14.3.9 BD Biosciences
14.3.10 Beckman Coulter
14.3.11 Partec
14.3.12 Sysmex
14.3.13 Apogee Flow Systems
14.3.14 PointCare Technologies Inc.
14.3.15 Zyomyx Inc.
14.3.16 Mylan inc.
14.3.17 Roche Diagnostics
14.3.18 Siemens Healthcare
14.3.19 Qiagen
14.3.20 BioMerieux
